ArticleCancer science2024
RETRACTION: MicroRNA-16 inhibits glioma cell growth and invasion through suppression of BCL2 and the nuclear factor-κB1/MMP9 signaling pathway.
Article in Cancer science, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
- Retraction of
Authors and funding
0 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Retraction: T.-Q. Yang, X.-J. Lu, T.-F. Wu, D.-D. Ding, Z.-H. Zhao, G.-L. Chen, X.-S. Xie, B. Li, Y.-X. Wei, L.-C. Guo, Y. Zhang, Y.-L. Huang, Y.-X. Zhou, and Z.-W. Du, "MicroRNA-16 inhibits glioma cell growth and invasion through suppression of BCL2 and the nuclear factor-κB1/MMP9 signaling pathway," Cancer Science 105 no. 3 (2014): 265-271. https://doi.org/10.1111/cas.12351. The above article, published online on 13 January 2014 in Wiley Online Library (wileyonlinelibrary.com), has been retracted by agreement between the journal Editor-in-Chief, Masanori Hatakeyama; the Japanese Cancer Association; and John Wiley and Sons Ltd. The journal had previously published a correction regarding duplicated portions of Figure 4a on 24 May 2022. Following publication of this correction, the journal was made aware that not all duplicated portions of Figure 4a had been replaced. Additionally, concerns were raised of splicing in Figure 2d and image duplications in Figures 2d, 3d, and 4c. The authors did not respond to inquiries from the publisher regarding these concerns. and did not provide the requested original images and data. Therefore, the data reported in this article are considered unreliable and the journal must issue a retraction. The authors did not respond to our notice of retraction.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.